FDA Inspection 1114727 — Sushruta Multispeciality Hospital & Research Centre Pvt. Ltd.
The FDA completed an inspection of Sushruta Multispeciality Hospital & Research Centre Pvt. Ltd. on Nov 7, 2019 in Hubli. The inspection was classified NAI (No Action Indicated — no objectionable conditions or practices were found during the inspection). Product area: Drugs.
Inspection details
- Classification
- No Action Indicated (NAI)
- End Date
- Nov 7, 2019
- Fiscal Year
- 2020
- Product Type
- Drugs
- Project Area
- Bioresearch Monitoring
- Location
- Hubli (India)
Additional details
Clinical BA/BE